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ABSTRACT 
 
Objectives: With the increase in reports of the failure of Paracetamol as antipyretic in pediatric patients and 
the increase in the use of Mefenamic acid, the study was undertaken to recommend best among the both 
antipyretics by comparing the efficacy and tolerability of both these drugs. 
Methods-It was a prospective, active treatment controlled study with follow up to 72 hours done over a 
period of 2 months after the Institutional Ethical committee approval. Total 124 pediatric patients with fever 
admitted to Pravara Rural Hospital, Loni having a body temperature >38.5 and fulfilling the inclusion and 
exclusion criteria were included. Patients included were categorized into two groups –group A and group B 
and  administered  Paracetamol  and  Mefenamic  acid  in  the  doses  15  mg/kg  and  4  mg/kg  body  weight 
respectively.  The  parameters  essential  for  comparing  the  efficacy  and  tolerability  were  observed  and 
recorded. The collected data were subjected to ‘paired t test’ of significance and was analyzed statistically. 
Results-Both  drugs  significantly  decreased  body  temperature  in  pediatric  patients  with  fever.  The 
antipyretic efficacy  of Mefenamic acid was highly  significant than Paracetamol (<0.05). No significant 
differences in adverse effects were noted in both the groups. Conclusion-Mefenamic acid was found to be 
more effective and equally tolerable than paracetamol as an antipyretic in pediatric patients with febrile 
illness and can be the best alternative to paracetamol. 
 
Keywords: Acetaminophen, Mefenamic acid, MTTES. 
 
INTRODUCTION 
 
Fever is one of the most important and common 
presenting symptom in pediatric clinics, outpatient 
departments  and  emergency. 
1  Fever  may  be 
defined  as  a  complex  physiologic  response  to  a 
disease,  mediated  by  pyrogenic  cytokines  and 
characterized  by  a  rise  in  core  temperature, 
generation of acute phase reactants and activation 
of  immune  systems
2.  Regulation  of  body 
temperature  requires  a  delicate  balance  between 
production  and  loss  of  heat,  the  hypothalamus 
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regulates  the  set-point  at  which  the  body 
temperature  is  maintained.  In  fever  this 
hypothalamus thermostat set point is elevated and 
body  temperature  increases  over  normal  values. 
The normal range of body temperature is 36.5
 º -
37.5
º C.
3 
In most clinical situations, fever results from the 
presence  of  the  substances  called  pyrogens. 
Various  infections,  toxins  and  other  mediators 
induce  production  of  pyrogens  by  host 
inflammatory  cells  such  as  macrophages, 
endothelial cells and lymphocytes. Best pyrogens 
are  endotoxins  (Lipopolysaccharides,  LPS) 
produced by gram negative bacilli. Gram positive 
bacteria also produce  pyrogens as their cell  wall 
has  peptidoglycan  and  Lipoteichoic  acid.  The 
endogenous  pyrogens  produced  locally  or 
systemically  gain  entrance  in  the  circulation  and 
produce  fever
.1,4.  The  major  fever  causing 
cytokines are various Interleukins (IL) IL-Iβ, IL-lα, 
1L-6, TNF-α  (Tumor  necrosis  factor)  and  INF-α 
(interferon).  These  pyrogenic  cytokines  directly 
stimulate  the  hypothalamus  to  produce  PGE2 
(prostaglandin  I2)  which  then  resets  the 
temperature  regulatory  set  point.  IL-1  is  an 
important  pyrogen  that  on  reaching  the 
hypothalamus  induces  fever  in  8-10  minutes 
time
1.When  the  pyrogenic  cytokines  disappear 
from  the  circulation  or  inhibition  of 
cyclooxygenase  by  the  metabolites,  the 
hypothalamus is again reset downward so now the 
heat  dissipation  mechanisms  come  into  play 
causing vasodilation and sweating.
 
It has been shown beyond doubt that increase in 
the temperature of the body puts the child under 
threat  of  convulsions,  dehydration,  metabolic 
acidosis and fever induced stroke. So Antipyresis 
is one of the most usual therapeutic interventions 
undertaken
. 1 
The  most  commonly  used  antipyretics  are 
Nonsteroidal Anti Inflammatory Drugs (NSAIDS), 
which  also  have  a  considerable  analgesic  effect 
which  promotes  a  general  feeling  of  well-being. 
Antipyretic treatment is now routinely prescribed 
to  febrile  children,  though  variedly  by  most 
pediatricians.  
Antipyresis  occurs  with  different  classes  of 
substance including Acetyl Salicylic Acid (ASA), 
Acetaminophen  and  the  other  nonsteroidal  anti-
inflammatory agents represented by Indomethacin, 
Mefenamic  acid,  Ibuprofen  and  the  latest 
Nimesulide.  Some  antipyretics  are  anti-
inflammatory.  NSAIDs  inhibit  cyclooxygenase 
(COX)  which  catalyzes  the  conversion  of 
arachidonic  acid  to  prostaglandin  E2.  This 
reduction  of  prostaglandin  E2  in  the  brain  is 
believed to lower the hypothalamic set point.
1, 4  
Aspirin, once a preferred drug is no longer used in 
reducing fever as it has potential to cause Reye's 
syndrome.  Acetaminophen,  Mefenamic  acid  and 
Nimesulide are currently three preferred drugs for 
treating fevers in children. 
Acetaminophen (paracetamol) antipyretic is in use 
for  a  considerable  time.  As  with  ASA,  the 
antipyretic effect of Paracetamol is believed to be 
caused  by  its  ability  to  decrease  prostaglandin 
synthesis in the brain. Since Paracetamol does not 
inhibit  the  synthesis  of  prostaglandins  in  the 
periphery,  it  does  not  possess  any  anti-
inflammatory action. Besides its beneficial effects 
PCM also has potential side effects and may cause 
severe hypersensitivity reactions
1,4. Nimesulide is a 
non-steroidal  anti-inflammatory  drug  with 
analgesic  and  antipyretic  properties.  Its  efficacy 
has  been  compared  with  naproxen,  ASA, 
paracetamol and Mefenamic acid but it is banned 
due  to  fulminant  hepatitis.
  Mefenamic  acid  is  a 
potent inhibitor of cyclooxygenase. It has a central 
as well as peripheral analgesic action. The drug is 
commonly  used  in  patients  with  injuries, 
osteoarthritis,  rheumatoid  arthritis  and 
dysmenorrhea.  The  pediatric  suspension  of 
Mefenamic  acid  is  recommended  50mg/5ml  or 
25mg/kg body weight in divided doses.
3-6 
It is essential to establish a cause for a fever and 
then provide effective modern treatment. Judicious 
use  of  the  antipyretics  needs  to  be  considered 
giving  due  respect  to  the  body's  response  to  the 
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infection  in  the  form  of  fever.  The  decision  to 
choose  an  antipyretic  should  be  dictated  by 
efficacy,  safety,  duration  of  action,  effectiveness 
and  cost. 
1 PCM  has  always  been  a  dependable 
antipyretic  and  has  an  additional  advantage  of 
being  a  cheaper  drug  and  relatively  safer 
antipyretic. There have been reports of failure of 
antipyretic  drugs  including  paracetamol  in 
controlling  fever  and  trends  of  increase  use  of 
Mefenamic acid as antipyretic. Moreover there are 
no studies  comparing efficacy  and tolerability  of 
Acetaminophen  and  Mefenamic  acid.    Hence  it 
was thought prudent to evaluate both these drugs 
for better antipyretic efficacy in pediatric patients 
with febrile illness. 
 
Aims and objectives 
1.  To  compare  the  efficacy  of  Acetaminophen 
(Paracetamol)  And  Mefenamic  Acid  in 
pediatric patients with fever. 
2.  To compare the tolerability and adverse effect 
of  Acetaminophen  (Paracetamol)  And 
Mefenamic  Acid  in  pediatric  patients  with 
fever 
3.  To  recommend  best  antipyretic  in  pediatric 
patients. 
 
MATERIALS AND METHODS 
 
This was a prospective observational clinical study 
done  in  collaboration  with  the  Department  of 
Pediatrics,  Pravara  Rural  Hospital,  Loni.  The 
Institutional  ethical  committee  approval  was 
obtained before the initiation of the study. 
Patients  diagnosed  by  Department  of  Pediatrics 
with  febrile  illness  were  enrolled  in  the  study 
according to the following inclusion and exclusion 
criteria. Written informed consent was taken from 
each patient. 
Inclusion criteria 
1.  Patients ready to give informed consent. 
2.  Hospitalized  children  having  temperature  > 
99.6
 º F 
3.  Patients 1-12 years. 
4.  Patients of either sex. 
5.  Patients of all types of febrile illness. 
Exclusion criteria 
1. Uncooperative patients. 
2. Patients not following the protocol. 
3. Patients above the age of 12 years. 
4. Patients who were hypersensitive to drugs. 
5. Patients having any inflammatory illness  
6. Severely ill patients suffering from circulatory 
collapse,  blood  dyscrasias,  cardiac  or  hepatic 
disease, G-6-PD deficiency or meningitis. 
7. Children  having  collagen  vascular  diseases  or 
malignancy as a primary or the underlying cause 
of  fever  and  those  receiving  antimicrobials 
and/or corticosteroids within 24 hours preceding 
the study. 
Study conduct 
This was a prospective, observational, comparative 
study with follow- up till 72 hours. A total of 124 
children having temperature > 99.6
 º F admitted to 
the Pediatrics ward, Pravara Rural Hospital, Loni 
were included in the study. 
Enrolled patients  were categorized  into 2  groups 
depending  on  antipyretic  treatment  given  by  the 
pediatricians: 
Group  A:  Paracetamol  treated  at  a  dose  of  15 
mg/kg given as suspension 
1, 10 
Group  B:    Mefenamic acid 4 mg/kg given as  a 
suspension. 
8 
Following parameters were recorded in each group 
for: 
1.  Efficacy evaluation
7 
Axillary temperature (measured with a mercury 
thermometer)   
  Before drug administration  
  Every 1 (H1), 4 (H4) and 6 (H6) h after the 
first dose. 
  Maximum temperature  
Withdrawal of the patient from the study 
  Body  temperature  increases  above  104°F  or 
decreased below 96.5 °C 
  Occurrence any severe physical event  
  Withdrawal  of  the  consent  of  the 
parents/guardians. 
2.  Tolerability evaluation 
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Modified Treatment Tolerability Evaluation Score 
(MTTES)
 7,11:   
Vomiting, dislikeness for meals, daytime sleep and 
additional  medication  were  assessed  and  scores 
were recorded from 0-3 (absent –severe): 
Score 0: Absent - Symptom is not present 
Score1:  Mild  -  Symptom  is  present  but  is  not 
annoying or troublesome 
Score  2:  Moderate  -  Symptom  is  frequently 
troublesome but would not interfere with normal 
daily activity or sleep 
Score  3:  Severe  -  Symptom  is  sufficiently 
troublesome to interfere with normal daily activity 
or sleep 
Symptoms  for  MTTES:  Vomiting,  Dislikeness 
for  meals,  Daytime  sleeping,  Additional 
medication 
The  primary  efficacy  and  tolerability  end  points 
were recorded as changes from the baseline values: 
Sample  size:  62  patients  were  included  in  each 
group according to inclusion and exclusion criteria.  
(Total  sample  size:  124  pediatric  patients  with 
fever) 
Study period: 2 months starting from the date of 
approval of the study by the Institutional Ethical 
Committee 
Statistical analysis: The data will be collected, 
pooled, subjected to appropriate statistical analysis 
and conclusions were drawn
RESULTS AND OBSERVATIONS 
 
Fig:1. The change in mean values of all parameters from baseline to 6 hours during treatment of patients 
included in group A (Paracetamol) 
By  applying  Student’s  Paired  ‘t’  test  there  is  a 
highly significant decrease of body temperature in 
treatment group A (Paracetamol) from baseline to 
1 hour, 4 hours and 6 hours, 1 hour to 4 hours and 
6 hours, (i.e. p<0.01) and rest all other parameters 
remained constant at 4 and 6 hours 
Fig:2. Change in mean values of all parameters from baseline to 6 hours during treatment of group B 
(Mefenamic acid) 26  
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By  applying  Student’s  Paired  ‘t’  test  there  is  a 
highly significant decrease of body temperature in 
treatment group B (Mefenamic acid) from baseline 
to 1 hour, 4 hours and 6 hours, 1 hour to 4 hours 
and  6  hours,  (i.e.  p<0.01)  and  rest  all  other 
parameters remained constant at 4 and 6 hours 
 
Fig: 3. Comparison of average body temperature in group A and group B 
On  comparison  of  average  fall  in    body 
temperature in group A and group B after applying 
“Z”  test  of  significance  there  was  a  highly 
significant  difference  in  fall  in  temperature  in 
Group B from baseline to 1 hour than Group A. 
Both the groups showed a highly significant fall in 
temperature from baseline to 6 hours. 
 
 
Table:1. Distribution of average percentage fall (decrease) from baseline to 6 hours for all parameters in 
Group A (Paracetamol) and Group B (Mefenamic acid) (n=62) 
 
Parameters   Percentage (%) of fall (decrease) from baseline to 6 hours  
Group A (Paracetamol)  Group B (Mefenamic acid) 
Body temperature (ºC)  2.47%  3.23% 
Pulse rate(per min)  13.48%  15.11% 
Systolic Blood Pressure (mm of Hg)  3.74%  3.94% 
Diastolic Blood Pressure (mm of 
Hg) 
1.32%  3.86% 
Respiratory rate (per min)  15.17%  16.94% 
 
It is seen from the above table that the average fall 
(decrease) all parameters are significantly more in 
group  B  as  compared  to  group  A,  thus  it  is 
concluded  that  drug  Mefenamic  acid  is  more 
efficient  /  consistent  than  drug  paracetamol  in 
pediatric  patients  with  fever.  That  is  Mefenamic 
acid shows better and faster recovery of fever in 
pediatric patients as compared to Paracetamol.  
 
Table:2. Total number of patients suffered with following adverse effect 
Group  Vomiting  Dislikeness meal  Daytime sleeping  Additional medication 
Paracetamol(n=50)  3  5  5  2 
Mefenamic acid(n=50)  2  7  4  2 
Significance  P>0.05*  P>0.05*  P>0.05*  P>0.05* 
* No significant difference between mean values of MTTES scores between Paracetamol and Mefenamic acid group.  
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DISCUSSION 
The management of children with fever is based 
primarily on the elucidation and treatment of the 
underlying cause. The role of antipyretic therapy in 
such children is aimed at reducing the ever present 
risk  of  a  febrile  convulsion.  A  variety  of 
pharmacological  agents  are  available  for 
Antipyresis. The so called superiority of one drug 
over the other is marginal and has no therapeutic 
significance.
3, 12In our study both Paracetamol and 
Mefenamic acid proved to be effective antipyretic 
drugs. Antipyresis was achieved within 6 hours of 
administration of the dose. In Paracetamol group 
the  baseline  body  temperature  decreased  since 
101.81
 º to 99.29
 ºFat 6hours while in Mefenamic 
acid group from 102.12
 º to 98.82 
ºFat 6hours. Both 
the drugs are NSAIDs and act by inhibiting COX 
enzyme responsible for generating Prostaglandins 
(PGE2). Paracetamol has only central action with 
weak  anti-inflammatory  effect  and  so  has  been 
reported to be the best antipyretic drug. Mefenamic 
acid  has  central  and  peripheral  action  with  anti-
inflammatory effect. The fall in temperature at 1 hr 
was  more  in  Mefenamic  acid  group  (102.12
oF 
to99.5
oF)compared  with  paracetamol  group 
(101.81
oF  to  100.32
oF).These  results  show  that 
Mefenamic  acid  has  better  antipyresis  at  1  hour 
than Mefenamic acid. A rough correlation has been 
established between the anti synthetase activities of 
many  nonsteroidal  anti-inflammatory  drugs
13 
including  Mefenamic  acid  in  central  nervous 
system. Our results are in accord with S. Keininen 
etal which also states Mefenamic acid to be more 
potent  and  powerful  antipyretic  drug.
8.  The 
children showed no adverse symptoms or signs in 
connection with the antipyretic therapy. There was 
no  significant  difference  on  Heart  rate,  BP  and 
respiratory  rate  despite  a  slight  fall  in  all  above 
was noted. 
Mefenamic  Acid  shows  highly  significant 
decreases in the body temperature baseline to 6th 
hour  as  compared  to  Paracetamol  in  paediatric 
patients with  fever (i.e. P<0.01.) This may be due 
to decline in the efficacy of Paracetamol which has  
 
been  described  as  the  best  antipyretic.  It  is 
essential to establish a cause for a fever and then 
provide effective modern treatment.  
A persistent fever is a stimulus to both doctor and 
parents to maintain their vigilance. The use of the 
drugs  should  not  become  the  refuge  of  the 
diagnostically  destitute.  Judicious  use  of  the 
antipyretics  needs  to  be  considered  giving  due 
respect to the body's response to the infection in 
the  form  of  fever
9.  PCM  has  always  been  a 
dependable  antipyretic  and  has  an  additional 
advantage  of  being  a  cheaper  medicine  and 
relatively  safer  antipyretic.  Other  drugs  like 
Mefenamic acid have marginally better antipyresis. 
1Study  demands  more  detailed  evaluation  of  the 
decline in paracetamol efficacy. 
 
CONCLUSION 
 
It is clear from this study that Mefenamic Acid is 
the best antipyretic as in-terms of their efficacy and 
tolerability in pediatric patients with fever and can 
be  very  helpful  in  treating  febrile  illness  in 
pediatric age  group more  effectively. Mefenamic 
acid could be a suitable alternative as a "second-
line" antipyretic agent, even in selected children. 
However,  more  clinical  experience  and 
information  about  side-effects  are  needed  before 
they can be recommended for wider routine use. 
 
Our  study  results  showed  Mefenamic  acid  to  be 
more efficacious than Paracetamol as antipyretic in 
the Paediatric age group but more extensive studies 
and  clinical  experience  is  required  for  its 
recommendation  for  wider  use  as  antipyretic.  2. 
These  extensive  studies  should  address  safety  as 
well  as  efficacy  issues  and  should  be  compared 
using  all  possible  methods.  3.  More  extensive 
studies may yield a better antipyretic alternative to 
Paracetamol and  will also discourage injudicious 
use of antipyretic drugs like Nimesulide which is 
banned  but  still  used  by  some  pediatricians.  4. 
Genetic  studies  to  evaluate  the  decline  in  the 
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efficacy  of  paracetamol  as  antipyretic  should  be 
taken up. 
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